Press releases
- Masimo to Present in BofA Securities Health Care Conference
- Masimo Reports First Quarter 2024 Financial Results
- Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
- Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
- Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
- Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
- Politan Nominates Two Independent Candidates for Masimo Board
- Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
- Masimo Named One of Fast Company’s Most Innovative Companies in North America
- Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
More ▼
Key statistics
On Tuesday, Masimo Corp (3M4:BRN) closed at 126.83, 0.00% below its 52-week high of 126.83, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 126.83 |
---|---|
High | 126.83 |
Low | 126.83 |
Bid | 126.07 |
Offer | 126.75 |
Previous close | 126.83 |
Average volume | -- |
---|---|
Shares outstanding | 52.91m |
Free float | 48.85m |
P/E (TTM) | 83.16 |
Market cap | 6.44bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 15 minutes, as of Mar 26 2024.
More ▼